TrialAdvances in therapy2026
A Phase 1, Randomized, Open-Label Study to Assess the Bioequivalence of Trofinetide as a Ready-to-Use Oral Solution and Constituted Powder for Oral Solution in Healthy Adults.
Mona Darwish et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.